Y Moride

Summary

Country: Canada

Publications

  1. doi Antipsychotic use and myocardial infarction in older patients with treated dementia
    Antoine Pariente
    Faculty of Pharmacy, Universite de Montreal, Succursale Centre Ville, QC, Canada
    Arch Intern Med 172:648-53; discussion 654-5. 2012
  2. doi Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors
    A Pariente
    University Bordeaux Segalen, Bordeaux, France
    Neurology 78:957-63. 2012
  3. pmc Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: resolved and unresolved issues
    Yola Moride
    Faculty of Pharmacy, Universite de Montreal, Montreal, Quebec
    Can J Cardiol 24:293-300. 2008
  4. ncbi Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines
    Yola Moride
    Faculty of Pharmacy, Universite de Montreal, Canada
    Can J Clin Pharmacol 12:e201-11. 2005
  5. ncbi Suboptimal duration of antidepressant treatments in the older ambulatory population of Quebec: association with selected physician characteristics
    Yola Moride
    Faculty of Pharmacy, Université of Montréal, Quebec, Canada
    J Am Geriatr Soc 50:1365-71. 2002
  6. pmc Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study
    Yola Moride
    Faculty of Pharmacy, Universite de Montreal, Montreal, Canada
    Arthritis Res Ther 7:R333-42. 2005
  7. ncbi Persistency of use of COX-2-specific inhibitors and non-specific non-steroidal anti-inflammatory drugs (NSAIDs) in Quebec
    Y Moride
    Faculty of Pharmacy, Universityof Montréal and Centre for Clinical Epidemiology and Community Studies, SMBD Jewish General Hospital, Montreal, Quebec, Canada
    Rheumatology (Oxford) 42:iii17-22. 2003
  8. ncbi Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication
    Marie Pascale Guay
    Faculty of Pharmacy, University of Montreal, Montreal, Canada
    Pharmacoepidemiol Drug Saf 16:17-27. 2007
  9. ncbi Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials
    M Oremus
    Center for Clinical Epidemiology and Community Studies, S.M.B.D. Jewish General Hospital, Montreal, Canada
    Dement Geriatr Cogn Disord 12:232-6. 2001
  10. doi Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture
    Sylvie Perreault
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Pharmacoepidemiol Drug Saf 17:248-59. 2008

Collaborators

Detail Information

Publications33

  1. doi Antipsychotic use and myocardial infarction in older patients with treated dementia
    Antoine Pariente
    Faculty of Pharmacy, Universite de Montreal, Succursale Centre Ville, QC, Canada
    Arch Intern Med 172:648-53; discussion 654-5. 2012
    ..Antipsychotic use is associated with an increased risk of ischemic stroke in this population. Our study aimed to investigate the association of AP use with the risk of acute myocardial infarction (MI)...
  2. doi Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors
    A Pariente
    University Bordeaux Segalen, Bordeaux, France
    Neurology 78:957-63. 2012
    ..To determine the effect of treatment gaps on the risk of institutionalization or death among community-dwelling elderly patients treated with cholinesterase inhibitors (ChIs)...
  3. pmc Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: resolved and unresolved issues
    Yola Moride
    Faculty of Pharmacy, Universite de Montreal, Montreal, Quebec
    Can J Cardiol 24:293-300. 2008
    ..However, the benefit-risk ratio would likely be optimized through interventions designed to increase persistence and adherence in a real-life setting...
  4. ncbi Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines
    Yola Moride
    Faculty of Pharmacy, Universite de Montreal, Canada
    Can J Clin Pharmacol 12:e201-11. 2005
    ..Prescription practices following the publication of these guidelines and the introduction of COX-2 inhibitors in the Quebec formulary of reimbursed medications remain largely unexplored...
  5. ncbi Suboptimal duration of antidepressant treatments in the older ambulatory population of Quebec: association with selected physician characteristics
    Yola Moride
    Faculty of Pharmacy, Université of Montréal, Quebec, Canada
    J Am Geriatr Soc 50:1365-71. 2002
    ..To assess the association between selected physician characteristics and suboptimal duration of antidepressant use in the older outpatient population...
  6. pmc Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study
    Yola Moride
    Faculty of Pharmacy, Universite de Montreal, Montreal, Canada
    Arthritis Res Ther 7:R333-42. 2005
    ..At the time of introduction of COX-2 inhibitors into the formulary, prescription channeling could confound risk comparisons across products...
  7. ncbi Persistency of use of COX-2-specific inhibitors and non-specific non-steroidal anti-inflammatory drugs (NSAIDs) in Quebec
    Y Moride
    Faculty of Pharmacy, Universityof Montréal and Centre for Clinical Epidemiology and Community Studies, SMBD Jewish General Hospital, Montreal, Quebec, Canada
    Rheumatology (Oxford) 42:iii17-22. 2003
    ....
  8. ncbi Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication
    Marie Pascale Guay
    Faculty of Pharmacy, University of Montreal, Montreal, Canada
    Pharmacoepidemiol Drug Saf 16:17-27. 2007
    ..The WHI was stopped prematurely because of an increased risk of breast cancer, stroke and cardiovascular diseases (CVD) in the hormone replacement therapy (HRT) arm of the trial. Changes in the use of HRT are expected...
  9. ncbi Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials
    M Oremus
    Center for Clinical Epidemiology and Community Studies, S.M.B.D. Jewish General Hospital, Montreal, Canada
    Dement Geriatr Cogn Disord 12:232-6. 2001
    ..Also, it is composed of items that are well suited to the specific disease characteristics of AD. Further research should focus on the validity of this instrument...
  10. doi Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture
    Sylvie Perreault
    Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Pharmacoepidemiol Drug Saf 17:248-59. 2008
    ..But treatment rates for osteoporosis among high-risk patients are far below the recommended guidelines. A major concern about BSDs is the lack of adherence with treatment...
  11. ncbi Impact of a protocol for prevention of ventilator-associated pneumonia
    Rajae Omrane
    McGill University Health Center, Montreal, Quebec, Canada
    Ann Pharmacother 41:1390-6. 2007
    ..Several interventions have been shown to be effective in reducing the incidence of ventilator-associated pneumonia (VAP), but their implementation in clinical practice has not gained widespread acceptance...
  12. ncbi The depletion of susceptibles effect in the assessment of burden-of-illness: the example of age-related macular degeneration in the community-dwelling elderly population of Quebec
    Marie Tournier
    Center for Clinical Epidemiology and Community Studies, SMBD Jewish General Hospital, Montreal, Canada
    Can J Clin Pharmacol 15:e22-35. 2008
    ..With the aging of the population, age-related macular degeneration (AMD) is becoming a public health concern. Few studies have assessed its consequences on morbidity and mortality, and the findings are conflicting...
  13. ncbi Health survey data on potentially inappropriate geriatric drug use
    Claudine Laurier
    Policy and Outcomes at the Faculty of Pharmacy, Universite de Montreal, Quebec, Canada
    Ann Pharmacother 36:404-9. 2002
    ..Population survey data constitute an altemative way to study inappropriate use...
  14. ncbi Validation of a decision model for preventive pharmacological strategies in postmenopausal women
    Sylvie Perreault
    Faculty of Pharmacy, University of Montreal, Quebec, Canada
    Eur J Epidemiol 20:89-101. 2005
    ....
  15. doi Factors associated with persistence of cholinesterase inhibitor treatments in the elderly
    Antoine Pariente
    Faculty of Pharmacy, University of Montreal, QC, Canada
    Pharmacoepidemiol Drug Saf 19:680-6. 2010
    ..To identify factors associated with one-year persistence of cholinesterase inhibitor (ChI) treatments...
  16. ncbi Trends and determinants of antiresorptive drug use for osteoporosis among elderly women
    Sylvie Perreault
    Faculty of Pharmacy, University of Montreal, Montreal, Que, Canada
    Pharmacoepidemiol Drug Saf 14:685-95. 2005
    ..The objective is to estimate the rate ratio (RR) of having an ART prescription filled among elderly women and its relation to selected determinants from 1995 through 2001...
  17. ncbi Contemporary disease management in Quebec
    Amede Gogovor
    Health Management Research Group, Universite de Montreal, Quebec
    Healthc Q 11:30-7. 2008
    ..Future projects offer the promise of updated knowledge and continuously improved care and outcomes...
  18. ncbi A case-control analysis of nonsteroidal anti-inflammatory drugs and Alzheimer's disease: are they protective?
    C Wolfson
    Department of Epidemiology and Biostatistics, McGill University, Montreal, Que, Canada
    Neuroepidemiology 21:81-6. 2002
    ..Our findings, using a measure of drug use prior to symptom onset and not subject to recall bias, do not support a protective effect for NSAIDs...
  19. doi Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population
    Marie Tournier
    Center for Clinical Epidemiology and Community Studies, SMBD Jewish General Hospital, Montreal, Quebec, Canada
    J Affect Disord 115:160-6. 2009
    ..In a real-life setting, differences across newer antidepressants in patterns of use remain poorly explored, particularly in the older patients despite the high prevalence of late-life depression...
  20. pmc The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers
    Michel Rossignol
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada
    Br J Clin Pharmacol 67:118-24. 2009
    ..The aim of this study was to compare patterns of utilization of NSAIDs for musculoskeletal disorders (MSD) by occupation in a general employed population...
  21. ncbi Depression and mortality in the visually-impaired, community-dwelling, elderly population of Quebec
    Marie Tournier
    Centre for Clinical Epidemiology and Community Studies, Sir Mortimer B Davis SMBD Jewish General Hospital, Montreal, Quebec, Canada
    Acta Ophthalmol 86:196-201. 2008
    ..To assess the effect of visual impairment (VI) on the risk of depression or death in the community-dwelling elderly population...
  22. ncbi Evaluation of the Confusion Assessment Method (CAM) as a screening tool for delirium in the emergency room
    J Monette
    Division of Geriatric Medicine, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada
    Gen Hosp Psychiatry 23:20-5. 2001
    ..The implementation of systematic screening in populations at risk could increase the rate of early detection and lead to the appropriate management of delirious patients...
  23. doi Patterns of antidepressant use in Quebec children and adolescents: trends and predictors
    Marie Tournier
    Center for Clinical Epidemiology and Community Studies, SMBD Jewish General Hospital, Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada
    Psychiatry Res 179:57-63. 2010
    ..Although antidepressant use decreased after regulatory warnings, there appears to be a care gap between the evidence generated by efficacy studies and the products prescribed in a real-life setting...
  24. doi Benzodiazepine use and quality of sleep in the community-dwelling elderly population
    Sarah Gabrielle Beland
    Faculte de Pharmacie, Universite de Montreal, Montreal, Quebec, G8B 1S5 Canada
    Aging Ment Health 14:843-50. 2010
    ..About 50% of the elderly population report being dissatisfied with their sleep. Although benzodiazepines are the most prescribed drugs to treat sleep complaints, the effectiveness of their use on the quality of sleep is not well documented...
  25. ncbi Delirium in older emergency department patients discharged home: effect on survival
    Ritsuko Kakuma
    Department of Epidemiology and Biostatistics, McGill University, Montreal, QC, Canada
    J Am Geriatr Soc 51:443-50. 2003
    ..To determine whether prevalent delirium is an independent predictor of mortality in older patients seen in emergency departments (EDs) and discharged home without admission...
  26. pmc Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women
    Julie Blouin
    Faculties of Pharmacy, University of Montreal, Montreal, Quebec, Canada
    Br J Clin Pharmacol 66:117-27. 2008
    ..To evaluate the association between noncompliance with alendronate and risedronate and the risk of nonvertebral osteoporotic fracture in community-dwelling elderly women...
  27. doi Impact of prescriber nonresponse on patient representativeness
    Annie Fourrier-Reglat
    INSERM, Unité 657, IFR 99, Bordeaux, France
    Epidemiology 19:186-90. 2008
    ..Our objective was to compare the characteristics of patients whose prescriber did or did not respond...
  28. ncbi NSAID use profiles derived from reimbursement data in France
    Nicholas Moore
    Departement de Pharmacologie, EA3676, IFR99, Universite Victor Segalen Bordeaux 2, Bordeaux, France France
    Therapie 59:541-6. 2004
    ....
  29. ncbi Potential impact of oral contraceptive choice on myocardial infarction mortality and deep vein thrombosis
    Karin Martin
    Department of Pharmacology, Victor Segalen University, Bordeaux, France
    J Fam Plann Reprod Health Care 31:37-9. 2005
    ....
  30. ncbi Recommendations for the prevention of osteoporosis and fragility fractures. International comparison and synthesis
    Michel Rossignol
    McGill University
    Int J Technol Assess Health Care 18:597-610. 2002
    ....
  31. ncbi Infant and toddler disease score was useful for risk of hospitalization based on data from administrative claims
    Yann Mikaeloff
    INSERM, UMR S149, Paris, France
    J Clin Epidemiol 60:680-5. 2007
    ..To develop the infant and toddler disease score (IDS), a population-based predictive tool of morbidity status in infants and toddlers, based on data from administrative claims...
  32. ncbi Benzodiazepine use and risk of dementia: a nested case-control study
    Rajaa Lagnaoui
    Departement de Pharmacologie, Universite Victor Segalen, Bordeaux 2, 33 076 Bordeaux, France
    J Clin Epidemiol 55:314-8. 2002
    ..0; 95% CI, 0.6-1.6). Our finding suggest that former use of benzodiazepines could be a risk factor for dementia, but more detailed investigation are needed...
  33. ncbi Benzodiazepine utilization patterns in Alzheimer's disease patients
    Rajaa Lagnaoui
    Departement de Pharmacologie, Universite Victor Segalen, Bordeaux, France
    Pharmacoepidemiol Drug Saf 12:511-5. 2003
    ..Benzodiazepines (BZD) are commonly prescribed in the elderly. Persons with dementia may be at a greater risk of adverse reactions of BZD such as cognitive impairment...